Embedded Files
TissueGenix enables structured, multicellular 3D tissue constructs with an emphasis on design control, consistency, and speed of fabrication, while maintaining compatibility with standard plate-based assays.
Why TissueGenix
Rapid fabrication with control in standard well plates
Bottom-up bioprinting for faster iteration
Well-to-well consistency
Conventional 2D culture often lacks the physiological complexity needed for translationally meaningful readouts, while many conventional 3D approaches (such as spheroids) can require weeks of culture before they are ready for assays. In addition, these models are often heterogenous in size, shape, and composition, which compromises their scalability and reproducibility.
TissueGenix uses a fast, bottom-up bioprinting platform that generates structured tissue constructs with high precision, well-to-well consistency, and reproducibility in minutes, with models typically becoming assay-ready within days*. Our approach can significantly shorten assay turnaround, accelerate iteration, and improve cost-efficiency in a preclinical-friendly way.
*Timelines depend on model types and assay design; details are available upon request.
The Power of 3D Bioprinting
Precision manufacturing
Reproducible performance
Adaptability with common plate formats and readouts
Our proprietary 3D bioprinting technology allows for the creation of intricate, functional tissue models that provide a more realistic environment for drug testing. By moving beyond traditional methods, TissueGenix offers a platform for developing safer, more effective drugs in a fraction of the time.
Precision
TissueGenix's bioprinting platform enables high‑precision patterning of cells and biomaterials in micro-scale, allowing us to build structured tissue blocks with controlled architecture. This level of control enables the recreation of spatial organization and microenvironment context in vitro, supporting clear, interpretable readouts in plate-based assays.
Reproducibility
The bioprinting platform is designed for repeatable, standardized fabrication, producing tissue constructs with consistent geometry and composition from well to well. By prioritizing process control and stable build parameters, the platform supports reliable assay performance and reduces variability that can complicate screening and model development.
Adaptability
Our platform is design-friendly and configurable, allowing tissue designs to be adjusted to match different biological questions and assay needs. This adaptability supports applications from screening and assay development to disease modeling. The compatibility with conventional multiwell plate workflows also facilitate the integration with existing workflow and readout systems.
Page updated
Google Sites
Report abuse